Table 1 Clinicopathological characteristics of the 2 groups
| Â | Group A | Group B | P value | |
|---|---|---|---|---|
Age (Mean + SD) | 52.20 ± 6.39 | 47.80 ± 5.75 | 0.324 | |
Sex | Male | 19 (79.1%) | 17 (70.8%) | 0.572 |
| Â | Female | 5 (20.9%) | 7 (29.2%) | |
BMI (Mean + SD) | 35.8 + 7.47 | 31.4 + 6.41 | 0.253 | |
ASA score | I | 7 (29.2%) | 5 (20.9%) | 0.172 |
II | 13 (54.2%) | 16 (66.7%) | ||
III | 4 (16.7%) | 3 (12.5%) | ||
Pancreatic pathology | Pancreatic cancer | 18 (75%) | 16 (66.7%) | 0.218 |
Ampullary cancer | 4 (16.7%) | 5 (20.8%) | ||
distal cholangiocarcinoma | 2 (8.3%) | 4 (16.7%) | ||
Cholangitis (n, %) | 4 (16.7%) | 5 (20.8%) | 0.736 | |
Biliary stenting (n, %) | 16 (66.7%) | 18 (75%) | 0.652 | |
Comorbidities | Diabetes (n, %) | 12 (50%) | 10 (41.7%) | 0.653 |
| Â | Cardiovascular diseases (n, %) | 6 (25%) | 4 (16.7%) | 0.528 |